Kunzwisisa hukama pakati peMRD neCAR T-Cell therapy
What is MRD in cancer treatment? Measurable Residual Disease, or MRD, is the name for the very few cancer cells that stay in the body after or during treatment. Flow cytometry, polymerase chain reaction (PCR), or next-generati..
Mesenchymal stem cell therapy mune neurological kusagadzikana
Zvirwere zvetsinga matambudziko makuru pasi rose nekuti zvinokonzeresa kufa nekuremara kwakawanda. Kurapa kwechivanhu hakuna kushanda nguva dzose, izvo zvakonzera shanduko kune nzira itsva senge cell-based therapies. Beca..
Nherera zita remushonga rinopihwa neFDA kune CART T-Cell Therapy A2B530 yekurapa cancer cancer.
Muna Kurume 2024, kuburitswa kwenhau kwakataura kuti A2B530 (A2 Biotherapeutics), CAR T-cell therapy, yakapihwa Orphan Drug Dhizaini yekurapa colorectal cancer inoratidzira carcinoembryonic antigen (CEA) uye yakarasikirwa neHLA-A * 02 expr.
Iovance's Amtagvi inotenderwa neUSFDA sekutanga T-sero kurapa bundu rakasimba
Iovance Biotherapeutics 'yekutanga-ye-yayo-mhando immunotherapy yakabvumidzwa neFDA. Izvi zvinoreva kuti T-cell therapy, iyo yakashandura nzira iyo mamwe marudzi ekenza yeropa inorapwa, ikozvino inogona kushandiswa zvakananga pamamota akasimba.Mushonga.
Amivantamab-vmjw inotenderwa neUSFDA yeEGFR exon 20 yekuisa-yakashandurwa isiri-diki cell kenza yemapapu zviratidzo.
Food and Drug Administration yakabvumira amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) pamwe chete necarboplatin uye pemetrexed musi waKurume 1, 2024. Varwere vane epidermal growth factor receptor (EGFR) exon 20 insertio.
Osimertinib ine chemotherapy inotenderwa neUSFDA yeEGFR-yakashandurwa isiri-diki cell kenza yemapapu.
Chikafu neDrug Administration yakabvumidza osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP) pamwe chete neplatinamu-based chemotherapy kune varwere vane munharaunda yepamusoro kana metastatic isiri diki cell cancer yemapapu (la/mNSC.
Lifileucel inotenderwa neUSFDA kune isina kugadzirwa kana metastatic melanoma
Food and Drug Administration yakapa mvumo yakakurumidza ku lifileucel (Amtagvi, Iovance Biotherapeutics, Inc.) musi wa16 Kukadzi 2024. Mvumo iyi ndeyevarwere vakuru vane unrectable kana metastatic melanoma vanga vari.
Tepotinib inotenderwa neUSFDA kune metastatic isiri-diki cell cancer cancer
Chikafu neDrug Administration yakabvumidza zviri pamutemo tepotinib (Tepmetko, EMD Serono, Inc.) muna Kukadzi 15, 2024, yevarwere vakuru vane metastatic isiri-diki cell cancer cancer (NSCLC) yaive mesenchymal-epithelial shanduko (M.
Irinotecan liposome inotenderwa neUSFDA kune yekutanga-mutsara kurapwa kwe metastatic pancreatic adenocarcinoma.
Chikafu neDrug Administration yakabvumidza irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) ine oxaliplatin, fluorouracil, uye leucovorin musi waKukadzi 13, 2024, yekurapa metastatic pancreatic adenocarcinoma se ...
Erdafitinib inotenderwa neUSFDA kune yemuno advanced kana metastatic urothelial carcinoma
Erdafitinib (Balversa, Janssen Biotech) yakatenderwa neChikafu neDrug Administration muna Ndira 19, 2024, kuvarwere vakuru vane FGFR3 genetic shanduko vane munharaunda yepamusoro kana metastatic urothelial carcinoma (mUC). Patie..